Korea S.E.
23:00:00 19/05/2024 BST
5-day change
1st Jan Change
2,465
KRW
-2.18%
-3.71%
+22.94%
Naturalendo Tech Co., Ltd. announced that it has received KRW 5 billion in funding from LIG Investment & Securities Co., Ltd., Investment Arm
On October 11, 2016, Naturalendo Tech Co., Ltd. closed the transaction.
Naturalendo Tech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
19/03/23
CI
Naturalendo Tech Co., Ltd. announced that it has received KRW 4 billion in funding from Suheung Co., Ltd.
02/06/20
CI
Naturalendo Tech Co., Ltd. announced that it expects to receive KRW 4 billion in funding from Suheung Co., Ltd.
26/05/20
CI
Naturalendo Tech Co., Ltd.(KOSDAQ:A168330) dropped from S&P Global BMI Index
23/09/19
CI
Naturalendo Tech Co., Ltd. announced that it has received KRW 30 billion in funding from Nhc Limited
19/12/16
CI
Naturalendo Tech Co., Ltd. announced that it expects to receive KRW 30 billion in funding from Nhc Limited
15/12/16
CI
Naturalendo Tech Co., Ltd. announced that it has received KRW 5 billion in funding from LIG Investment & Securities Co., Ltd., Investment Arm
10/10/16
CI
Naturalendo Tech Co., Ltd. announced that it expects to receive KRW 5 billion in funding from LIG Investment & Securities Co., Ltd., Investment Arm
09/10/16
CI
Naturalendo Tech Co., Ltd. announced that it has received KRW 5 billion in funding from KDB Daewoo Securities Co. Ltd., Investment Arm, Samsung Securities Co. Ltd., Investment Arm, NH Investment & Securities Co., Ltd., Investment Arm
29/08/16
CI
Suheung Co., Ltd. completed the acquisition of 3.71% stake in Naturalendo Tech Co., Ltd..
03/11/15
CI
Suheung Co., Ltd. acquired 3.71% stake in Naturalendo Tech Co., Ltd. for SKW 15 billion.
01/11/15
CI
Tranche Update on Naturalendo Tech Co., Ltd.'s Equity Buyback Plan announced on April 28, 2015.
27/07/15
CI
Naturalendo Tech Co., Ltd ’s Equity Buyback announced on April 27, 2015 has closed with 180,000 shares, representing 0.93% for KRW 5,809.97 million.
23/07/15
CI
Morgan Stanley Investment Management Company and 10 related parties acquired 3% stake in Naturalendo Tech Co., Ltd..
06/05/15
CI
Naturalendo Tech Co., Ltd. announces an Equity Buyback for 180,000 shares, for KRW 9,594 million.
27/04/15
CI
Naturalendo Tech Co., Ltd authorizes a Buyback Plan.
26/04/15
CI
KB Investment & Securities Co., Ltd, Investment Arm acquired 0.84% stake in Naturalendo Tech Co., Ltd. from Jae-soo Kim and Cheol Hwan Kim for KRW 5.5 billion.
25/07/14
CI
Naturalendo Tech Co., Ltd. has completed an IPO in the amount of KRW 21.20 billion.
25/10/13
CI
Naturalendo Tech Co., Ltd. has filed an IPO in the amount of KRW 28.62 billion.
02/07/13
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Naturalendo Tech Co.,Ltd. is a Korea-based company principally engaged in the research and development (R&D) and manufacture of hormone biotechnology products. The Company mainly provides novel phytoestrogen, which is applied in the treatment of climacteric. It also provides other hormonal formula, such as hormone disruptor inhibitor, secretagogue and inhibitor used as diet formula and growth hormone. In addition, the Company provides materials used for diet, and involves in the R&D of drug delivery systems, immune enhancer, atopy and acne, plantation factory, and others.
More about the company
1st Jan change
Capi.
+22.94% 57.22M +20.12% 20.76B 0.00% 19.32B +11.99% 12.59B -15.78% 9.03B +23.93% 8.1B +9.36% 5.93B -2.84% 4.46B -17.38% 3.81B -9.91% 3.59B
Cosmetics & Perfumes
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
NATURALENDO TECH CO., LTD. 
